Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D Minna

Showing results (201-210 of 286) with videos related to

Pageof 29
Sort By:
Journal of Medical Genetics|July 5, 2005
Cloned fusion product from a rare t(15;19)(q13.2;p13.1) inhibit S phase in vitroN Haruki, K S Kawaguchi, S Eichenberger, et al.
Cancer Treatment Reports|May 1, 1977
Intensive chemotherapy of small cell bronchogenic carcinomaM H Cohen, P J Creaven, B E Fossieck, et al.
British Journal of Cancer|July 4, 1998
p53 mutations in non-small-cell lung cancers occurring in individuals without a past history of active smokingY Takagi, H Osada, T Kuroishi, et al.
Cancer|January 15, 1982
Erythroleukemia and other hematologic complications of intensive therapy in long-term survivors of small cell lung cancerE C Bradley, G P Schechter, M J Matthews, et al.
Cancer Research|April 28, 2001
5' CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancerS Zöchbauer-Müller, K M Fong, A Maitra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1990
Ten-year survival of patients with small-cell lung cancer treated with combination chemotherapy with or without irradiationB E Johnson, J Grayson, R W Makuch, et al.
The Journal of Clinical Investigation|June 1, 1987
myc family oncogene amplification in tumor cell lines established from small cell lung cancer patients and its relationship to clinical status and courseB E Johnson, D C Ihde, R W Makuch, et al.
The Pharmacogenomics Journal|December 27, 2006
The DRD2 TaqI-B polymorphism and its relationship to smoking abstinence and withdrawal symptomsJ D Robinson, C Y Lam, J A Minnix, et al.
Oncogenesis|August 21, 2013
NeuroD1 regulation of migration accompanies the differential sensitivity of neuroendocrine carcinomas to TrkB inhibitionJ K Osborne, J E Larsen, J X Gonzales, et al.
Science (New York, N.Y.)|October 27, 1989
p53: a frequent target for genetic abnormalities in lung cancerT Takahashi, M M Nau, I Chiba, et al.
Pageof 29

Showing results (201-210 of 286) with videos related to

Sort By:
Pageof 29
Journal of Medical Genetics|July 5, 2005
Cloned fusion product from a rare t(15;19)(q13.2;p13.1) inhibit S phase in vitroN Haruki, K S Kawaguchi, S Eichenberger, et al.
Cancer Treatment Reports|May 1, 1977
Intensive chemotherapy of small cell bronchogenic carcinomaM H Cohen, P J Creaven, B E Fossieck, et al.
British Journal of Cancer|July 4, 1998
p53 mutations in non-small-cell lung cancers occurring in individuals without a past history of active smokingY Takagi, H Osada, T Kuroishi, et al.
Cancer|January 15, 1982
Erythroleukemia and other hematologic complications of intensive therapy in long-term survivors of small cell lung cancerE C Bradley, G P Schechter, M J Matthews, et al.
Cancer Research|April 28, 2001
5' CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancerS Zöchbauer-Müller, K M Fong, A Maitra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1990
Ten-year survival of patients with small-cell lung cancer treated with combination chemotherapy with or without irradiationB E Johnson, J Grayson, R W Makuch, et al.
The Journal of Clinical Investigation|June 1, 1987
myc family oncogene amplification in tumor cell lines established from small cell lung cancer patients and its relationship to clinical status and courseB E Johnson, D C Ihde, R W Makuch, et al.
The Pharmacogenomics Journal|December 27, 2006
The DRD2 TaqI-B polymorphism and its relationship to smoking abstinence and withdrawal symptomsJ D Robinson, C Y Lam, J A Minnix, et al.
Oncogenesis|August 21, 2013
NeuroD1 regulation of migration accompanies the differential sensitivity of neuroendocrine carcinomas to TrkB inhibitionJ K Osborne, J E Larsen, J X Gonzales, et al.
Science (New York, N.Y.)|October 27, 1989
p53: a frequent target for genetic abnormalities in lung cancerT Takahashi, M M Nau, I Chiba, et al.
Pageof 29